Sequenom, Inc. (SQNM) was a life sciences company that provided genetic testing services and diagnostic reagents. The company developed and marketed noninvasive prenatal testing (NIPT) for genetic abnormalities, such as Down syndrome.
In 2017, Sequenom was acquired by LabCorp, a global life sciences company that provides diagnostic and drug development services. After the acquisition, Sequenom's NIPT technology was integrated into LabCorp's offerings.
Sequenom, Inc. (SQNM) was a life sciences company that provided genetic testing services and diagnostic reagents. The company developed and marketed noninvasive prenatal testing (NIPT) for genetic abnormalities, such as Down syndrome.